Skip to main content
. 2007 Apr 23;51(7):2546–2551. doi: 10.1128/AAC.01550-06

TABLE 1.

Patient characteristics at the time of the pharmacokinetic assessment

Characteristic Value at rifampin dose (mg):
600 450
n 23 24
No. (%) male 12 (52) 13 (54)
Age (yr) [median (range)] 27 (18-55) 34 (19-55)
Wt (kg) [mean (SD)] 47.3 (6.9) 48.4 (8.1)
Body mass index (kg/m2) [mean (SD)] 18.4 (2.6) 18.8 (2.7)
No. with diabetes mellitus (%) 1/23 (4) 2/24 (8)
HIV positive (%) 0 1 (4)
Rifampin dose (mg/kg) [mean (SD)] 12.9 (1.7) 9.5 (1.4)